Pulmonx (LUNG) Non-Current Deferred Tax Liability (2019 - 2025)

Pulmonx (LUNG) has reported Non-Current Deferred Tax Liability for 7 consecutive years, with $69000.0 the latest figure, recorded in Q4 2025.

• On a quarterly basis, Non-Current Deferred Tax Liability fell 20.69% year-over-year to $69000.0 in Q4 2025; TTM through Dec 2025 was $69000.0, a 20.69% decrease from a year earlier, with the FY2025 full-year figure at $69000.0, down 20.69% from the prior year.
• Non-Current Deferred Tax Liability was $69000.0 for Q4 2025 at Pulmonx, up from $47000.0 in the prior quarter.
• Over five years, Non-Current Deferred Tax Liability peaked at $1.3 million in Q4 2023 and troughed at $37000.0 in Q4 2021.
• A 5-year average of $137500.0 and a median of $71000.0 in 2021 frame the typical range for Non-Current Deferred Tax Liability.
• Across the five-year window, Non-Current Deferred Tax Liability jumped 1265.96% in 2023 and slumped 93.22% in 2024, its largest moves.
• Over 5 years, Non-Current Deferred Tax Liability stood at $37000.0 in 2021, then soared by 154.05% to $94000.0 in 2022, then jumped by 1265.96% to $1.3 million in 2023, then tumbled by 93.22% to $87000.0 in 2024, then slipped by 20.69% to $69000.0 in 2025.
• The last three Non-Current Deferred Tax Liability figures came in at $69000.0 (Q4 2025), $47000.0 (Q3 2025), and $41000.0 (Q2 2025), per Business Quant data.